← Human Trials & Peer-Reviewed Studies

A Multimodal Ultrasound Observation Study on the Effect of Vitamin D on Uterine Fibroids in Non-menopausal Women.

Plain-language guide to PMID 37921154 (2024): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.

Key Facts

PMID
37921154
Journal
Current medical imaging
Year
2024
Study type
Randomized Controlled Trial
Authors
Wang Q et al. (6 authors)
DOI
10.2174/0115734056281479231030053817

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

The purpose of this study was to evaluate the effect of vitamin D on the size, hardness, and blood flow of uterine fibroids in premenopausal women by multimodal ultrasound.

Why It Was Studied

It has been reported in the literature that Vitamin D can inhibit the growth of uterine fibroids, but the evaluation index is only the size of the uterine fibroids.

Who Took Part

The age groups tagged for this paper are adults, women only.

How the Study Was Run

In design terms this was a randomized study.

The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

What Was Measured

It has been reported in the literature that Vitamin D can inhibit the growth of uterine fibroids, but the evaluation index is only the size of the uterine fibroids.

The subject headings attached to it are Leiomyoma, Vitamin D, Ultrasonography, Uterine Neoplasms, Vitamin D Deficiency, Multimodal Imaging and Premenopause.

Author keywords: Pre-menopausal women, Uterine fibroids, blood flow grade, elastic strain ratio and multimodal ultrasound.

What This Means in Plain Language

The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc.

Results are reported in around 6 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2024 (Current medical imaging), a journal based in United Arab Emirates.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.